Receptors, Lysophosphatidic Acid
"Receptors, Lysophosphatidic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subfamily of lysophospholipid receptors with specificity for LYSOPHOSPHATIDIC ACIDS.
| Descriptor ID |
D049368
|
| MeSH Number(s) |
D12.776.543.750.695.420.249
|
| Concept/Terms |
Receptors, Lysophosphatidic Acid- Receptors, Lysophosphatidic Acid
- Acid Receptors, Lysophosphatidic
- Lysophosphatidic Acid Receptors
- Lysophosphatidic Acid Receptor
- Acid Receptor, Lysophosphatidic
- LPA Receptors
- Receptors, LPA
- Receptor, Lysophosphatidic Acid
LPA2 Receptor- LPA2 Receptor
- Receptor, LPA2
- Edg-4 Receptor
- Edg 4 Receptor
- Receptor, Edg-4
- Edg4 Protein
LPA3 Receptor- LPA3 Receptor
- Receptor, LPA3
- Edg-7 Receptor
- Edg 7 Receptor
- Receptor, Edg-7
- EDG7 Protein
LPA1 Receptor- LPA1 Receptor
- Receptor, LPA1
- vzg-1 Receptor
- Receptor, vzg-1
- vzg 1 Receptor
- LPA-1 Receptor
- LPA 1 Receptor
- Edg2 Protein
- edg-2 Receptor
- Receptor, edg-2
- edg 2 Receptor
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Lysophosphatidic Acid".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Lysophosphatidic Acid".
This graph shows the total number of publications written about "Receptors, Lysophosphatidic Acid" by people in this website by year, and whether "Receptors, Lysophosphatidic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Lysophosphatidic Acid" by people in Profiles.
-
Genetic variation associated with circulating monocyte count in the eMERGE Network. Hum Mol Genet. 2013 May 15; 22(10):2119-27.
-
Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions. Mol Pharmacol. 2012 Dec; 82(6):1162-73.
-
Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy. Biochim Biophys Acta. 2013 Jan; 1831(1):74-85.
-
Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells. Am J Pathol. 2012 May; 180(5):2170-81.
-
Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene. 2011 Mar 17; 30(11):1351-9.
-
Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid. Mol Cancer. 2010 Jun 09; 9:140.
-
ATX-LPA receptor axis in inflammation and cancer. Cell Cycle. 2009 Nov 15; 8(22):3695-701.
-
Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell. 2009 Jun 02; 15(6):539-50.
-
Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect. J Biol Chem. 2009 May 22; 284(21):14558-71.
-
Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. J Natl Cancer Inst. 2008 Nov 19; 100(22):1630-42.